Company Filing History:
Years Active: 2010
Title: Innovations by Curtis R Kelly in Glaucoma Treatment
Introduction
Curtis R Kelly is an accomplished inventor based in Arlington, TX. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach focuses on utilizing specific agents to address eye disorders effectively.
Latest Patents
Curtis R Kelly holds a patent for a method of treating glaucoma that involves administering α-lipoic acid. This invention provides compositions and methods aimed at treating glaucoma, ocular hypertension, and age-related macular degeneration. The patent emphasizes the use of agents that down-regulate the expression of tanis and/or p21 genes to treat these eye disorders.
Career Highlights
Curtis R Kelly is associated with Alcon, Inc., a leading company in eye care products. His work at Alcon has allowed him to focus on developing innovative solutions for eye health, contributing to advancements in the treatment of various ocular conditions.
Collaborations
Throughout his career, Curtis has collaborated with notable colleagues, including Colene D Drace and Gary W Williams. These partnerships have fostered a collaborative environment that enhances the development of new treatments and technologies in ophthalmology.
Conclusion
Curtis R Kelly's contributions to glaucoma treatment through his innovative patent demonstrate his commitment to improving eye health. His work continues to influence the field and offers hope for better management of ocular disorders.